Survey: 1 in 3 patients used no opioids prescribed after surgery

Nearly one-third of patients said they did not use any of the opioids they were prescribed after surgery, and just 8 percent of patients said they got rid of their remaining opioids, according to a survey conducted by Rochester, Minn.-based Mayo Clinic.

Advertisement

Mayo Clinic physicians and researchers surveyed 1,907 patients who underwent 25 common surgeries at three academic medical centers.

Here are five survey findings.

1. Nearly all of the patients in the survey (92 percent) received an opioid prescription at discharge. However, the number of opioids patients needed after discharge varied depending on the surgery they underwent.

2. Sixty-three percent of the opioids prescribed went unused.

3. The majority of patients (90 percent) said they were satisfied with their pain control.

4. Over one-fourth of patients (28 percent) felt they were prescribed too many opioids, while 8 percent said they were prescribed too few.

5. The median amount of opioids consumed per patient was approximately six pills of 5-milligram oxycodone.

“This research provides a road map for physicians and surgical departments. It shows there are certain surgeries and types of patients who are likely receiving significantly more opioids than needed,” said senior author Elizabeth Habermann, PhD.

More articles on opioids: 
Sanders bill proposes 10-year prison sentence for pharma execs marketing opioids
No criminal charges brought for Prince’s drug overdose
Opioid issues sideline maternal mortality bills in Congress

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.